Soluble Guanylate Cyclase Activators to Treat Benign Prostatic Hyperplasia and associated LUTS

This review summarises the presentations during a workshop session entitled “The Use of Soluble Guanylate Cyclase Activators to Treat Benign Prostatic Hyperplasia, Obstruction and Fibrosis – Mechanistic Concepts and Clinical Implications” at the International Continence Society (ICS) 2021 Melbourne...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanai, A.J., Andersson, K.-E., Birder, L.A., Fry, C.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310070/
https://www.ncbi.nlm.nih.gov/pubmed/37389026
http://dx.doi.org/10.1016/j.cont.2023.100699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310070/
https://www.ncbi.nlm.nih.gov/pubmed/37389026
http://dx.doi.org/10.1016/j.cont.2023.100699

Ejemplares similares